Published in Cancer Weekly, June 17th, 1996
This Phase III study demonstrated for the first time that adding chemotherapy to a standard treatment of prednisone can significantly reduce the pain and suffering of patients with advanced prostate cancer, and extend the duration of relief.
Management of severe and unrelenting pain is key to patients' quality of life and functioning, which also affects family members. Anti-cancer drugs can be toxic, so they...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.